A kind of refining method of daclatasvir hydrochloride

A technology of daclatasvir hydrochloride and refining method, which is applied in the field of medicine, and can solve the problems of difficult scale-up production, difficult removal, low yield, etc.

Active Publication Date: 2022-01-18
YANGTZE RIVER PHARM GRP CO LTD
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Its shortcoming is that after the crude product is dissolved in methanol, part of the methanol needs to be concentrated, which is not conducive to operation, difficult to scale up production, and low yield
Because there are 4 chiral centers in daclatasvir hydrochloride, there will inevitably be isomer impurities in the crude product, and it is difficult to remove. The purity of the product prepared by this method is not high, and the impurities, especially isomer impurities, etc. poor removal

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of refining method of daclatasvir hydrochloride
  • A kind of refining method of daclatasvir hydrochloride
  • A kind of refining method of daclatasvir hydrochloride

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] 10 g of crude daclatasvir hydrochloride was dissolved in 45 ml of methanol and stirred at 60°C until dissolved. Add 0.4g of activated carbon, stir at 60°C for 30 minutes, filter while it is hot, add a mixed solvent of 50ml of acetone and 50ml of isopropanol dropwise to crystallize the filtrate when it is heated to 60°C, and crystallize at 20-30°C for 2 hours after the addition is completed, filter , and the filter cake was vacuum-dried at 50° C. to obtain 8.7 g of off-white solid, with a yield of 87%, a chromatographic purity of 99.87%, a maximum heterogeneity of 0.07%, and an isomer of 0.05%.

Embodiment 2

[0033] 10 g of crude daclatasvir hydrochloride was dissolved in 50 ml of methanol and stirred at 58°C until dissolved. Add 0.8g of activated carbon, stir at 65°C for 30 minutes, filter while it is hot, add a mixed solvent of 50ml of acetone and 50ml of isopropanol dropwise to crystallize the filtrate when the temperature is raised to 60°C, and crystallize at 20-30°C for 2 hours after the addition is completed, filter , and the filter cake was vacuum-dried at 50° C. to obtain 8.6 g of a white solid, with a yield of 86%, a chromatographic purity of 99.70%, a maximum heterogeneity of 0.07%, and an isomer of 0.07%.

Embodiment 3

[0035] 10 g of crude daclatasvir hydrochloride was dissolved in 60 ml of methanol and stirred at 55°C until dissolved. Add 0.4g of activated carbon, stir at 65°C for 30 minutes, filter while it is hot, add a mixed solvent of 50ml of isopropanol and 50ml of acetone to crystallize the filtrate when it is heated up to 60°C, and crystallize at 20-30°C for 2 hours after the addition is complete, and filter , and the filter cake was vacuum-dried at 50° C. to obtain 8.5 g of white solid, with a yield of 85%, a chromatographic purity of 99.87%, and a maximum single heterogeneity of 0.07%. Isomers: none.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for refining daclatasvir hydrochloride, which comprises the following steps: (1) adding crude daclatasvir hydrochloride to methanol and dissolving at 55-65°C; (2) adding activated carbon at 55-65°C (3) Filtration, the resulting filtrate is warmed up to 55-65°C, and the mixed solvent of water-soluble aprotic solvent A and protic solvent B is added dropwise for crystallization. ) filtering step (3) stirring the crystallized mixture, and vacuum-drying the obtained filter cake to obtain high-purity daclatasvir hydrochloride. The method of the present invention can effectively remove the impurities in the crude product of daclatasvir hydrochloride, the product purity is above 99.5%, the isomer impurities and other single impurities are not more than 0.1%, and the refining yield is not less than 85%. In addition, the present invention The refining method has a simple and convenient process, and the process is easy for industrialized production.

Description

technical field [0001] The invention belongs to the field of medicine and relates to a method for refining high-purity daclatasvir hydrochloride. Background technique [0002] Daclatasvir hydrochloride is a selective hepatitis C virus (HCV) nonstructural protein 5a replication complex inhibitor with high specificity for multiple HCV genotypes / subtypes and low toxicity to host cells. [0003] Daclatasvir hydrochloride was developed by Bristol-Myers Squibb, and was approved by the European Union at the end of 2014. It is used in combination with other drugs for the treatment of adults with genotype 1, 2, 3, and 4 chronic hepatitis C (HCV) infection. Daclatasvir hydrochloride is currently on the market in the United Kingdom, Japan and the United States, and its clinical treatment effect is that the average cure rate reaches 95%, and the cure rate for adults with genotype 1 chronic hepatitis C infection is even close to 100%. On April 28, 2017, the State Food and Drug Administr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D403/14
CPCC07D403/14
Inventor 鲍鹤龄徐浩宇蔡伟刘景龙申新程钱斌董志奎曹兵朱晶
Owner YANGTZE RIVER PHARM GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap